Atypical antipsychotic medication poisoning: An evidence-based consensus guideline for out-of-hospital management

Clinical Toxicology

Volumn 45, Issue 8, 2007, Pages 918-942

  Cobaugh, Daniel J ^a   Erdman, Andrew R ^a   Booze, Lisa L ^a   Scharman, Elizabeth J ^a   Christianson, Gwenn ^a   Manoguerra, Anthony S ^a   Caravati, E Martin ^a   Chyka, Peter A ^a   Woolf, Alan D ^a   Nelson, Lewis S ^a   Troutman, William G ^a  

^a American Association of Poison Control Centers   (United States)

Author keywords

Antipsychotics; Atypical poisoning; Poison control centers standards; Practice guidelines

Indexed keywords

ACTIVATED CARBON; ALCOHOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMPHETAMINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BICARBONATE; CLOZAPINE; DIPHENHYDRAMINE; DOPAMINE; GLUCOSE; HYPERTENSIVE FACTOR; INFUSION FLUID; INSULIN; IPECAC; LAXATIVE; LORAZEPAM; METHYLPHENIDATE; OLANZAPINE; OXYGEN; PARACETAMOL; QUETIAPINE; RISPERIDONE; SODIUM CHLORIDE; UNINDEXED DRUG; VALPROIC ACID; ZIPRASIDONE; ZOPICLONE;

AGITATION; AIRWAY; AMBULANCE; ARTIFICIAL VENTILATION; AUTISM; BIPOLAR DISORDER; CAREGIVER; DROWSINESS; DRUG INTOXICATION; DRUG OVERDOSE; EMERGENCY WARD; FOLLOW UP; HEALTH CARE PERSONNEL; HEART MONITORING; HEART MUSCLE CONDUCTION DISTURBANCE; HOSPITAL; HUMAN; HYPOTENSION; INGESTION; INTUBATION; OXYGEN THERAPY; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PATIENT TRANSPORT; POISON CENTER; RESUSCITATION; REVIEW; SCHIZOPHRENIA; SEDATION; SINGLE DRUG DOSE; SLEEP; TOUCH; VOICE; VOMITING;

AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; POISON CONTROL CENTERS; POISONING; PRACTICE GUIDELINES AS TOPIC; TRIAGE;

EID: 37549048682     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701665142     Document Type: Review

References (137)

1. Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. Am J Psychiatry 2004; 161:677-684.
2. Casey DE. Seroquel (quetiapine): Preclinical and clinical findings of a new atypical antipsychotic. Exp Opin Investig Drugs 1996; 5:939-957.
3. Abilify [package insert]. New York, NY: Bristol-Meyers Squibb, 2006.
4. Clozaril [package insert]. Basel: Novartis Pharmaceuticals, 2005.
5. Wolters EC, Hurwitz TA, Peppard RF, Calne DB. Clozapine: An antipsychotic agent in Parkinson's disease? Clin Neuropharmacol 1989; 12:83-90.
6. Zyprexa [package insert]. Indianapolis, IN: Eli Lilly & Co, 2006.
7. Seroquel [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals, 2007)
8. Risperdal [package insert]. Titusville, NJ: Janssen, 2007.
9. Geodon [package insert]. New York, NY: Pfizer, 2007.
10. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281:1900-1905.
11. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139:493-498.
12. Buckley NA. Antipsychotic drugs (neuroleptics). In: Dart RC, ed. Medical Toxicology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004:861-870.
13. Burns, M. The antipsychotic drugs. In: Haddad LM, Shannon MW, Winchester JF, eds. Clinical Management of Poisoning and Drug Overdose. 3rd ed. Philadelphia: WB Saunders, 1998:628-641.
14. Burns M. Neuroleptic agents. In: Brent J, Wallace KL, Burkhart KK, Phillips SD, Donovan JW, eds. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Philadelphia: Elsevier Mosby, 2005:505-521.
15. De Roos FJ. Neuroleptics. In: Ford MD, Delaney KA. Ling J, Erickson T, eds. Clinical Toxicology. Philadelphia: WB Saunders, 2001:539-545.
16. LoVecchio F, Lwein NA. Antipsychotics. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill, 2002:875-884.
17. Klasco RK, ed. Poisindex. Greenwood Village (CO): Thomson Micromedex, edition expires March 2004.
18. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States. Advance data from vital and health statistics; no. 314. Hyattsville (MD): National Center for Health Statistics, 2000. Available at 〈http://www.cdc.gov/nchs/ data/ad/ad314.pdf〉
19. Davenport JD, McCarthy MW, Buck ML. Excessive somnolence from aripiprazole in a child. Pharmacotherapy 2004; 24:522-525.
20. LoVecchio F, Watts D, Winchell J. One-year experience with aripiprazole exposures [letter]. Am J Emerg Med 2005; 23:585-586.
21. Schonberger RB, Douglas L, Baum CR. Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole. Pediatrics 2004; 114:1743.
22. Lofton AL, Klein-Schwartz W. Prospective multi-poison center study of ziprasidone exposures [abstract]. J Toxicol Clin Toxicol 2004; 42:726.
23. Seifert SA, Schwartz MD, Thomas JD. Aripiprazole (Abilify) overdose in a child. Clin Toxicol (Phila) 2005; 43:193-195.
24. Forrester MB. Aripiprazole exposures reported to Texas poison control centers during 2002-2004. J Toxicol Environ Health A. 2006; 69:1719-1726.
25. Le Blaye I, Donatini B, Hall M, Krupp P. Acute overdosage with clozapine: Review of the available clinical experience. Pharm Med 1992; 6:169-178.
26. Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol 2000; 3:51-54.
27. Borzutzky A, Avello E, Rumie H, Paris E. Accidental clozapine intoxication in a ten-year-old child. Vet Hum Toxicol 2003; 45:309-310.
28. Mady S, Wax P, Wang D, Goetz C, Hadley C, Love R. Pediatric clozapine intoxication. Am J Emerg Med 1996; 14:462-463.
29. Warden CR, Pace SA. Clozapine overdose in a child presenting with acute respiratory arrest [abstract]. J Toxicol Clin Toxicol 1996; 34:571.
30. Bond GR, Thompson JD. Olanzapine pediatric overdose [letter]. Ann Emerg Med 1999; 34:292-293.
31. Chambers RA, Caracansi A, Weiss G. Olanzapine overdose cause of acute extrapyramidal symptoms. Am J Psychiatry 1998; 155:1630-1631.
32. Yip L, Dart RC, Graham K. Olanzapine toxicity in a toddler [letter]. Pediatrics 1998; 102:1494.
33. Catalano G, Cooper DS, Catalano MC, Butera AS. Olanzapine overdose in an 18-month-old child. J Child Adolesc Psychopharmacol 1999; 9:267-271.
34. Juhl GA, Benitez JG, McFarland S. Acute quetiapine overdose in an eleven-year-old girl. Vet Hum Toxicol 2002; 44:163-164.
35. Acri AA, Henretig FM. Effects of risperidone in overdose. Am J Emerg Med 1998; 16:498-501.
36. Gesell LB, Stephen M. Toxicity following a single dose of risperidone for pediatric attention deficit hyperactivity disorder (ADHD) [abstract]. J Toxicol Clin Toxicol 1997; 35:549.
37. Cheslik TA, Erramouspe J. Extrapyramidal symptoms following accidental ingestion of risperidone in a child. Ann Pharmacother 1996; 30:360-363.
38. Kuspis D, Dean B, Krenzelok EP. Risperidone overdose assessment [abstract]. J Toxicol Clin Toxicol 1995; 33:552.
39. Lackey G, Alsop J, Albertson T. Ziprasidone: A 12-month review of acute overdoses [abstract]. J Toxicol Clin Toxicol 2002; 40:685.
40. Bryant SM, Zilberstein J, Cumpston KL, Magdziarz DD, Costerisan DD. A case series of ziprasidone overdoses. Vet Hum Toxicol 2003; 45:81-82.
41. LoVecchio F, Watts D, Eckholdt P. Three-year experience with ziprasidone exposures [letter]. Am J Emerg Med 2005; 23:586-587.
42. Carstairs SD, Williams SR. Overdose of aripiprazole, a new type of antipsychotic. J Emerg Med 2005; 28:311-313.
43. Reith D, Monteleone JP, Whyte IM, Ebelling W, Holford NH, Carter GL. Features and toxicokinetics of clozapine in overdose. Ther Drug Monit 1998; 20:92-97.
44. Bedry R, Deschamps L, Pehourcq F, Moore N, Pillet O, Favarel-Garrigues JC. Non-fatal clozapine (LEPONEX) intoxication with toxicokinetic evaluation. Vet Hum Toxicol 1999; 41:20-22.
45. Broich K, Heinrich S, Marneros A. Acute clozapine overdose: Plasma concentration and outcome. Pharmacopsychiatry 1998; 31:149-151.
46. Browne R, Larkin C. Clozapine: An accidental overdose. Eur Psychiatry 1997; 12:266-267.
47. Cohen LG, Fatalo A, Thompson BT, Di Centes Bergeron G, Flood JG, Poupolo PR. Olanzapine overdose with serum concentrations. Ann Emerg Med 1999; 34:275-278.
48. Hadley C, Griffith J, Casavant M. "Mellow yellow" - intentional abuse of clozapine [abstract]. J Toxicol Clin Toxicol 2003; 41:743.
49. Levinson B. Letter: clozapine (Leponex) overdosage. S Afr Med J 1975; 49:5.
50. Meeker JE, Herrmann PW, Som CW, Reynolds PC. Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril. J Anal Toxicol 1992; 16:54-56.
51. Piccini G, Ceroni P, Marchesi C, Maggini C, Maestri G. Acute clozapine overdosage. Br J Psychiatry 1997; 170:290.
52. Pollak PT, Shafer SL. Teaching application of clinical pharmacology skills using unusual observations from clozapine overdoses. J Clin Pharmacol 2004; 44:141-149.
53. Renwick AC, Renwick AG, Flanagan RJ, Ferner RE. Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose. J Toxicol Clin Toxicol 2000; 38:325-328.
54. Roy DM, Cutten AE. Clozapine overdose with pronounced neutrophilia: A case report. Aust N Z J Psychiatry 1993; 27:530-531.
55. Sartorius A, Hewer W, Zink M, Henn FA. High-dose clozapine intoxication. J Clin Psychopharmacol 2002; 22:91-92.
56. Schuster P, Gabriel E, Kufferle B, Strobl G, Karobath M. Reversal by physostigmine of clozapine-induced delirium. Clin Toxicol 1977; 10:437-441.
57. Stevens I, Gaertner HJ. Plasma level measurement in a patient with clozapine intoxication. J Clin Psychopharmacol 1996; 16:86-87.
58. Thomas L, Pollak PT. Delayed recovery associated with persistent serum concentrations after clozapine overdose. J Emerg Med 2003; 25:61-66.
59. Welber MR, Nevins S. Clozapine overdose, a case report. J Emerg Med 1995; 13:199-202.
60. Wolf LR, Otten EJ. A case report of clozapine overdose [abstract]. Vet Hum Toxicol 1991; 33:370.
61. Palenzona S, Meier PJ, Kupferschmidt H, Rauber-Luethy C. The clinical picture of olanzapine poisoning with special reference to fluctuating mental status. J Toxicol Clin Toxicol 2004; 42:27-32.
62. Powell G, Nelson L, Hoffman R. Overdose with olanzapine (Zyprexa®), a new antipsychotic agent [abstract]. J Toxicol Clin Toxicol 1997; 35:550.
63. Bajaj V, Comyn DJ. Norepinephrine in the treatment of olanzapine overdose. Anaesthesia 2002; 57:1040-1041.
64. Bosch RF, Baumbach A, Bitzer M, Erley CM. Intoxication with olanzapine. Am J Psychiatry 2000; 157:304-305.
65. Davis LE, Becher MW, Tlomak W, Benson BE, Lee RR, Fisher EC. Persistent choreoathetosis in a fatal olanzapine overdose: Drug kinetics, neuroimaging, and neuropathology. Am J Psychiatry 2005; 162:28-33.
66. Dobrusin M, Lokshin P, Belmaker RH. Acute olanzapine overdose. Hum Psychopharmacol 1999; 14:355-356.
67. Dougherty TJ, Greene TF, Farrell SE. Adult and pediatric olanzapine (Zyprexa®) overdose [abstract]. J Toxicol Clin Toxicol 1997; 35:550.
68. Etienne L, Wittebole X, Liolios A, Hantson P. Polyuria after olanzapine overdose [letter]. Am J Psychiatry 2004; 161:1130.
69. Fogel J, Diaz JE. Olanzapine overdose. Ann Emerg Med 1998; 32:275-276.
70. Gardner DM, Milliken J, Dursun SM. Olanzapine overdose. Am J Psychiatry 1999; 156:1118-1119.
71. Johal BK, Shelly MP. Olanzapine overdose [letter]. Anaesthesia 2000; 55:929.
72. Mazzola JL, Bird SB, Brush DE, Boyer EW, Aaron CK. Anticholinergic syndrome after isolated olanzapine overdose [abstract]. J Toxicol Clin Toxicol 2003; 41:472.
73. O'Malley G, Seifert S, Heard K, Yip L. Pupillary effects of olanzapine overdose mimic opiate and α-2 agonists [abstract]. J Toxicol Clin Toxicol 1998; 36:523.
74. O'Malley GF, Seifert S, Heard K, Daly F, Dart RC. Olanzapine overdose mimicking opioid intoxication. Ann Emerg Med 1999; 34:279-281.
75. Shrestha M, Hendrickson RG, Henretig FM. Striking extrapyramidal movements seen in large olanzapine overdoses [abstract]. J Toxicol Clin Toxicol 2001; 39:282.
76. Stephens BG, Coleman DE, Baselt RC. Olanzapine-related fatality. J Forensic Sci 1998; 43:1252-1253.
77. Suchard J, Erickson R. Serotonin syndrome from acute olanzapine overdose [abstract]. J Toxicol Clin Toxicol 2004; 42:718.
78. Wiener SW, Hoffman RS, Nelson LS. Smoking: A novel route of olanzapine abuse [abstract]. J Toxicol Clin Toxicol 2003; 41:742.
79. Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: A case series. Ann Emerg Med 2003; 42:751-758.
80. Lynch S, Fill S, Hoffman RS. Intentional quetiapine (Seroquel®) overdose [abstract]. J Toxicol Clin Toxicol 1999; 37:631.
81. Beelen AP, Yeo KT, Lewis LD. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol 2001; 20:215-219.
82. Catalano G, Catalano MC, Agustines RE, Dolan EM, Paperwalla KN. Pediatric quetiapine overdose: A case report and literature review. J Child Adolesc Psychopharmacol 2002; 12:355-361.
83. Fernandes PP, Marcil WA. Death associated with quetiapine overdose. Am J Psychiatry 2002; 159:2114.
84. Galdos Barroso M, Ulla Anes M, Martinez Vicente S, Arozemena Baquerizo J. Intoxicación por quetiapina [letter]. Med Clin (Barc) 2001; 117:638-639.
85. Harmon TJ, Benitez JG, Krenzelok EP, Cortes-Belen E. Loss of consciousness from acute quetiapine overdosage. J Toxicol Clin Toxicol 1998; 36:599-602.
86. Hendrickson RG, Morocco AP, Greenberg MI. False positive urine immunoassay for tricyclic antidepressants following quetiapine (Seroquel®) overdose [abstract]. J Toxicol Clin Toxicol 2001; 39:490.
87. Hustey FM. Acute quetiapine poisoning. J Emerg Med 1999; 17:995-997.
88. Kurth J, Maguire G. Pediatric case report of quetiapine overdose and QTc prolongation. Ann Clin Psychiatry 2004; 16:229-231.
89. Nudelman E, Vinuela LM, Cohen CI. Safety in overdose of quetiapine: A case report. J Clin Psychiatry 1998; 59:433.
90. Pais VM, Ayvazian PJ. Priapism from quetiapine overdose: First report and proposal of mechanism. Urology 2001; 58:462.
91. Pollak PT, Zbuk K. Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther 2000; 68:92-97.
92. Raja M, Azzoni A. Valproate and quetiapine overdose with benign outcome: A case report. Int J Psychiatry Clin Pract 2002; 6:173-174.
93. Rivera W, Gracia R, Roth B, Velez L, Garrison J, Idemudia S. Quinidine-like effects from quetiapine overdose with documented serum levels [abstract]. J Toxicol Clin Toxicol 2003; 41:508.
94. Smith RP, Puckett BN, Crawford J, Elliott RL. Quetiapine overdose and severe rhabdomyolysis. J Clin Psychopharmacol 2004; 24:343.
95. Vivek S. No QT interval prolongation associated with quetiapine overdose. Am J Emerg Med 2004; 22:330.
96. Heather GS, Vicas IMO. Risperidone overdose: A case series [abstract]. Vet Hum Toxicol 1994; 36:371.
97. Isbister GK, Whyte IM. Atypical presentation of risperidone toxicity [letter]. Vet Hum Toxicol 2002; 44:118-119.
98. Brown K, Levy H, Brenner C, Leffler S, Hamburg EL. Overdose of risperidone. Ann Emerg Med 1993; 22:1908-1910.
99. Catalano G, Catalano MC, Nuñez CY, Walker SC. Atypical antipsychotic overdose in the pediatric population. J Child Adolesc Psychopharmacol 2001; 11:425-434.
100. Catalano G, Catalano MC, Taylor W. Acute risperidone overdose. Clin Neuropharmacol 1997; 20:82-85.
101. Dueñas-Laita A, Castro-Villamor MA, Martin-Escudero JC, Perez-Castrillon JL. New clinical manifestations of acute risperidone poisoning. J Toxicol Clin Toxicol 1999; 37:893-895.
102. Himstreet JE, Daya M. Hypotension and orthostasis following a risperidone overdose. Ann Pharmacother 1998; 32:267.
103. Hodge CH, Jewell M, Gummin DD, Leikin JB. Atypical presentation of risperidone toxicity. Vet Hum Toxicol 2001; 43:339-341.
104. Lee HS, Tan CH, Au LS, Khoo YM. Serum and urine risperidone concentrations in an acute overdose. J Clin Psychopharmacol 1997; 17:325-326.
105. LoVecchio F, Hamilton RJ, Hoffman RJ. Risperidone overdose. Am J Emerg Med 1996; 14:95-96.
106. Moore NC, Shukla P. Risperidone overdose. Am J Psychiatry 1997; 154:289-290.
107. Nishikage H, Nakanishi T, Takamitsu Y, Yamamoto J. Sequential changes in the plasma concentration of risperidone following intentional overdose. Clin Neuropharmacol 2002; 25:307-309.
108. Springfield AC, Bodiford E. An overdose of risperidone. J Anal Toxicol 1996; 20:202-203.
109. Lackey G, Alsop J, Albertson T. A one-year review of pediatric ziprasidone ingestions [abstract]. J Toxicol Clin Toxicol 2002; 40:624.
110. Burton S, Heslop K, Harrison K, Barnes M. Ziprasidone overdose. Am J Psychiatry 2000; 157:835.
111. House M. Overdose of ziprasidone. Am J Psychiatry 2002; 159:1061-1062.
112. Bonin MM, Burkhart KK. Olanzapine overdose in a 1-year-old male. Pediatr Emerg Care 1999; 15:266-267.
113. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics 2000; 41:63-65.
114. Keller T, Miki A, Binda S, Dirnhofer R. Fatal overdose of clozapine. Forensic Sci Int 1997; 86:119-125.
115. Kochhar S, Nwokike JN, Jankowitz B, Sholevar EH, Abed T, Baron DA. Olanzapine overdose: A pediatric case report. J Child Adolesc Psychopharmacol 2002; 12:351-353.
116. Kopala LC, Day C, Dillman B, Gardner D. A case of risperidone overdose in early schizophrenia: A review of potential complications. J Psychiatry Neurosci 1998; 23:305-308.
117. Cesena M, Gonzalez-Heydrich J, Szigethy E, Kohlenberg TM, DeMaso DR. A case series of eight aggressive young children treated with risperidone. J Child Adolesc Psychopharmacol 2002; 12:337-345.
118. Croonenberghs J, Fegert JM, Findling RL, De Smedt G, Van Dongen S. Risperidone in children with disruptive behavior disorders and subaverage intelligence: A 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiatry 2005; 44:64-72.
119. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991; 41:369-371.
120. Findling RL, Maxwell K, Wiznitzer M. An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull 1997; 33:155-159.
121. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11:239-250.
122. Gagliano A, Germano E, Pustorino G, Impallomeni C, D'Arrigo C, Calamoneri F, Spina E. Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications. J Child Adolesc Psychopharmacol 2004; 14:39-47.
123. Gonzalez-Heydrich J, Pandina GJ, Fleisher CA, Hsin O, Raches D, Bourgeois BF, Biederman J. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: A case series. J Child Adolesc Psychopharmacol 2004; 14:295-310.
124. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 2005; 58:589-594.
125. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996; 53:1090-1097.
126. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA. Olanzapine versus haloperidol in children with autistic disorder: An open pilot study. J Am Acad Child Adolesc Psychiatry 2001; 40:887-894.
127. Masi G, Cosenza A, Mucci M, Brovedani P. Open trial of risperidone in 24 young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 2001; 40:1206-1214.
128. Masi G, Cosenza A, Mucci M, De Vito G. Risperidone monotherapy in preschool children with pervasive developmental disorders. J Child Neurol 2001; 16:395-400.
129. Masi G, Cosenza A, Mucci M, Brovedani P. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. J Clin Psychiatry 2003; 64:1039-1047.
130. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002; 347:314-321.
131. Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. J Clin Psychopharmacol 1999; 19:37-44.
132. Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB. Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 2000; 39:292-299.
133. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004; 114:e634-641.
134. Stephens RJ, Bassel C, Sandor P. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. J Child Adolesc Psychopharmacol 2004; 14:255-266.
135. Vercellino F, Zanotto E, Ravera G, Veneselli E. Open-label risperidone treatment of 6 children and adolescents with autism. Can J Psychiatry 2001; 46:559-560.
136. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 2001; 40:4S-23S.
137. Lofton AL, Klein-Schwartz W. Atypical experience: A case series of pediatric aripiprazole exposures. Clin Toxicol (Phila) 2005; 43:151-153.